InflaRx NV buy Guggenheim
Start price
05.04.23
/
50%
€4.97
Target price
05.04.24
€7.32
Performance (%)
-71.61%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. The BUY prediction by Guggenheim for InflaRx NV performed very badly with a performance of -71.61%. Guggenheim has a follow-up prediction for InflaRx NV where he still thinks InflaRx NV is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InflaRx NV | 6.333% | 6.333% | 100.393% | -54.993% |
| iShares Core DAX® | 3,15 % | 1,50 % | 9,13 % | 62,82 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % | 28,64 % | 85,80 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % | 53,03 % | 77,33 % |
| iShares S&P 500 | 4,58 % | 1,92 % | 23,97 % | 69,68 % |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten